NEW YORK (GenomeWeb News) – Cogenics said today that it will provide the Danish pharmaceutical company H. Lundbeck with genotyping services to support clinical drug studies.
Under the agreement, the Clinical Data subsidiary will conduct genotyping in its labs in Morrisville, NC, and in Bernried, Germany, for Lundbeck’s Phase I clinical trials. Cogenics said the period of the agreement is open-ended and that the companies plan to collaborate on other projects in the future.
Lundbeck is focused on developing and marketing drugs for treating psychiatric and neurological disorders.
Financial terms of the agreement were not released.